Notice: 21194711
Notice of Development of Rulemaking
Department: DEPARTMENT OF LEGAL AFFAIRS
Chapter: SCHEDULING AND RESCHEDULING OF CONTROLLED SUBSTANCES

VIEW NOTICE

Overview


RULE:
2-40.007   Rescheduling of a Drug Product in Finished Dosage Formulation That Has Been Approved by the U.S. Food and Drug Administration That Contains Cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) Derived from Cannabis and No More Than 0.1 Percent (w/w) Residual Tetrahydrocannabinols
RULEMAKING AUTHORITY: 893.0355, F.S.
LAW: 893.0355, F.S.
PRINT PUBLISH DATE: 11/27/2018   Vol. 44/229

RELATED STATUTES
AND LAWS:
893.0355, F.S., 893.0355, F.S.

OVERSIGHT COMMITTEE: Joint Administrative Procedures Committee
Florida Administrative Law Central Online Network (F.A.L.C.O.N.)

RELATED COURT CASES: Division of Administrative Hearings

FEDERAL eRULEMAKING
WEB PORTAL:
Regulations.gov

HOW TO LINK TO
THIS NOTICE:
http://flrules.org/gateway/ruleno.asp?id=2-40.007&PDate=11/27/2018&Section=1
REFERENCE MATERIALS: No reference(s).